What is the latest price of Sotorasib in 2024?

Sotorasib, a small molecule inhibitor targeting the KRAS G12C gene mutation in non-small cell lung cancer (NSCLC), has garnered significant attention since its debut. Its distinctive targeted mechanism of action showcases remarkable therapeutic potential in patients harboring this genetic mutation.

What is the latest price of Sotorasib in 2024?

According to market research, in 2024, the price of Sotorasib varies due to differences between the original drug and generic versions. The original drug is manufactured by Amgen in the United States, with a specification of 120mg*240 capsules, priced at approximately ¥80,155 per box.

Numerous generic drug manufacturers have also emerged in the market, with Sotorasib produced by Everest Medicines in Bangladesh available in a specification of 120mg*56 capsules, priced at around ¥4,900 per box; the same specification manufactured by Lucius Pharmaceuticals in Laos is priced at approximately ¥2,850 per box, and the version produced by Boiron Pharmaceuticals in Paraguay, with a specification of 120mg*120 capsules, is priced at around ¥7,500 per box. These prices are for reference only, as specific prices may vary due to policy adjustments, market supply and demand, and purchasing channels. Sotorasib is a prescription drug, and patients should have a thorough understanding of its mechanism of action, indications, contraindications, and potential side effects before use.

What are the side effects of Sotorasib?

While patients focus on the price of Sotorasib, they should not overlook the potential side effects it may bring. The common side effects of Sotorasib include:

1. Fatigue

Fatigue is one of the most common adverse reactions to Sotorasib. Patients may experience physical exhaustion, and weakness, impacting their daily lives and work.

2. Hepatotoxicity

Sotorasib may exert a certain toxic effect on the liver, leading to abnormal liver function. Patients using Sotorasib need to undergo regular liver function tests to ensure liver health.

3. Cough

Some patients may experience cough symptoms after taking Sotorasib. This may result from the drug's stimulating effect on the respiratory tract.

[warm tips] When using Sotorasib, patients should follow medical advice, take the medication on time and as prescribed, and should not adjust the dosage or stop the medication independently. During the course of treatment, patients should pay close attention to their condition and seek medical attention promptly if they experience any discomfort or unusual reactions.